Access Statistics for Katharina Elisabeth Blankart

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Hard Look at “Soft” Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany 0 0 1 13 0 6 20 52
A hard look at soft cost-control measures in healthcare organizations: Evidence from preferred drug policies in Germany 0 0 0 12 0 0 13 53
The Effects of Off-label Drug Use on Disability and Medical Expenditure 0 0 0 9 0 2 12 27
The effects of off-label drug use on disability and medical expenditure 0 0 0 2 1 3 10 20
Total Working Papers 0 0 1 36 1 11 55 152


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention 0 0 0 3 0 1 7 88
A systematic review of coverage decision-making on health technologies—Evidence from the real world 0 0 0 20 0 5 10 85
Analysing coverage decision-making: opening Pandora’s box? 0 0 0 3 1 3 6 41
Are patients more adherent to newer drugs? 0 0 0 1 2 4 8 33
Arzneimittel: Placebo bei Engpassbekämpfung 0 0 0 1 0 2 5 9
Dispensing behaviour of pharmacies in prescription drug markets 0 0 0 4 1 2 9 43
Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark 0 0 0 1 2 3 6 40
Early Benefit Assessment of Pharmaceuticals in Germany 0 0 0 1 0 4 10 14
Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation 0 0 0 0 0 1 5 5
Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe 0 0 0 1 0 1 3 5
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia 0 0 1 11 0 0 5 57
Improving Service Provision - The Health Care Services' Perspective 0 0 0 0 3 3 19 31
Insurance barriers and inequalities in health care access: evidence from dual practice 0 0 0 1 1 3 16 26
Link between Process and Appraisal in Coverage Decisions 0 0 0 0 1 2 8 8
Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany 0 0 0 0 0 3 5 6
Policy as a strategy to innovate in health care? A content analysis of innovation policies in Germany, 1994–2017 0 0 0 1 0 0 2 8
Regional Innovation Systems of Medical Technology: A knowledge production function of cardiovascular research and funding in Europe 0 0 0 2 1 5 12 21
The challenges of regulatory pluralism 0 0 0 0 0 3 12 13
The diffusion of generics after patent expiry in Germany 0 0 0 10 0 1 6 72
The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany 0 1 1 6 1 5 13 48
The impact of physician-level drug budgets on prescribing behavior 0 0 0 5 1 2 9 34
To Seek Program Accreditation, Innovation, or Both?—Examining the Interdependencies in High-Reliability Health Care Organizations 0 0 0 2 0 2 7 13
Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis 0 0 0 5 0 1 6 46
Total Journal Articles 0 1 2 78 14 56 189 746


Statistics updated 2026-06-04